TCL Archive In Brief: RFPs For Recompeting Frederick Contract Still Being Drafted; Panel Meets April 13 April 10, 1981
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up December 26, 2014
TCL Archive Congressional Appropriations Committee Leaders Blast White Plans To Slash NIH FY 1987 Budget February 20, 1987
